Skip to content
Screener

Roivant Sciences ROIV Cost of revenues

Cost of revenues at other companies

CuriosityStream logo
CuriosityStreamCURI
$6.66M-6.0%
Natera, Inc. logo
Natera, Inc.NTRA
$266.6M+33.6%
Janus International Group logo
Janus International GroupJBI
$125.2M+19.6%
Janus International Group logo
Janus International GroupJBI
$22.3M-27.8%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$3.26B+4.4%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$3.31B+10.3%

Segments

By segment

See full
Reportable Segment$284K+84.4%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25B+214%
Enterprise value$25.03B+215%
P/S3,318.5×+2,976×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept roiv:OperatingCosts.

The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001635088-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Revenue$1,442$2,170
Operating expenses:
Cost of revenues284154
Research and development (includes $8,721 and $11,099 of share-based compensation expense for the three months ended June 30, 2026 and 2025, respectively)202,016152,919
General and administrative (includes $74,621 and $71,079 of share-based compensation expense for the three months ended June 30, 2026 and 2025, respectively)165,527134,019
Total operating expenses367,827287,092
Gain on litigation settlement392
Loss from operations(365,993)(284,922)

Item 1. Financial Statements (Unaudited).

FAQ

What is Roivant Sciences's cost of revenues?
Roivant Sciences (ROIV) reported cost of revenues of $284K in Q2 2026.
How has Roivant Sciences's cost of revenues changed year-over-year?
Roivant Sciences's cost of revenues increased by 84.4% year-over-year, from $154K to $284K.
What is the long-term trend for Roivant Sciences's cost of revenues?
Over 3 years (2021 to 2025), Roivant Sciences's cost of revenues has grown at a -47.7% compound annual growth rate (CAGR), from $8.97M to $1.29M.
What does cost of revenues mean?
Operating costs represent the direct expenses incurred to generate revenue from the company's commercial products. This excludes R&D and administrative overhead, focusing strictly on the cost of goods sold or direct service delivery.

Ask your AI about Roivant Sciences's cost of revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude